Nuveen Nasdaq 100 Dynamic Overwrite Fund (NASDAQ:QQQX - Get Free Report) was the target of a large drop in short interest in April. As of April 15th, there was short interest totalling 21,900 shares, a drop of 40.0% from the March 31st total of 36,500 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 175,900 shares, the days-to-cover ratio is presently 0.1 days.
Institutional Trading of Nuveen Nasdaq 100 Dynamic Overwrite Fund
A number of large investors have recently made changes to their positions in QQQX. Private Advisor Group LLC grew its position in Nuveen Nasdaq 100 Dynamic Overwrite Fund by 9.8% in the fourth quarter. Private Advisor Group LLC now owns 26,613 shares of the company's stock worth $720,000 after acquiring an additional 2,380 shares in the last quarter. D.A. Davidson & CO. boosted its holdings in shares of Nuveen Nasdaq 100 Dynamic Overwrite Fund by 2.9% in the 4th quarter. D.A. Davidson & CO. now owns 86,103 shares of the company's stock worth $2,329,000 after purchasing an additional 2,451 shares during the period. Allspring Global Investments Holdings LLC increased its position in shares of Nuveen Nasdaq 100 Dynamic Overwrite Fund by 54.8% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 287,681 shares of the company's stock valued at $7,782,000 after purchasing an additional 101,821 shares during the last quarter. Sovran Advisors LLC purchased a new stake in Nuveen Nasdaq 100 Dynamic Overwrite Fund during the 4th quarter valued at $244,000. Finally, Stratos Wealth Partners LTD. raised its holdings in Nuveen Nasdaq 100 Dynamic Overwrite Fund by 39.0% during the 4th quarter. Stratos Wealth Partners LTD. now owns 23,251 shares of the company's stock valued at $629,000 after buying an additional 6,518 shares during the period. 23.62% of the stock is currently owned by institutional investors.
Nuveen Nasdaq 100 Dynamic Overwrite Fund Stock Up 0.3 %
Shares of NASDAQ QQQX traded up $0.08 during midday trading on Friday, reaching $24.28. 120,605 shares of the stock traded hands, compared to its average volume of 122,306. The company's 50 day moving average is $23.74 and its 200 day moving average is $25.60. Nuveen Nasdaq 100 Dynamic Overwrite Fund has a one year low of $20.34 and a one year high of $27.95.
Nuveen Nasdaq 100 Dynamic Overwrite Fund Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Friday, March 14th were paid a $0.56 dividend. The ex-dividend date of this dividend was Friday, March 14th. This represents a $2.24 dividend on an annualized basis and a dividend yield of 9.23%.
Nuveen Nasdaq 100 Dynamic Overwrite Fund Company Profile
(
Get Free Report)
Nuveen Nasdaq 100 Dynamic Overwrite Fund is a closed-ended equity indexed mutual fund launched by Nuveen Investments, Inc The fund is co-managed by Nuveen Asset Management, LLC and Nuveen Fund Advisors LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors.
See Also
Before you consider Nuveen Nasdaq 100 Dynamic Overwrite Fund, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nuveen Nasdaq 100 Dynamic Overwrite Fund wasn't on the list.
While Nuveen Nasdaq 100 Dynamic Overwrite Fund currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.